65 related articles for article (PubMed ID: 1889913)
1. Lack of gastric adverse effects of erdosteine in rats and men.
De Giovanni L; Fregnan GB; Rabitti C; Murari G; Amato A; Sovera A; Civello IM
Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):269-73. PubMed ID: 1889913
[TBL] [Abstract][Full Text] [Related]
2. The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study.
Moretti M; Bottrighi P; Dallari R; Da Porto R; Dolcetti A; Grandi P; Garuti G; Guffanti E; Roversi P; De Gugliemo M; Potena A;
Drugs Exp Clin Res; 2004; 30(4):143-52. PubMed ID: 15553660
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of glucosamine against ibuprofen-induced peptic ulcer in rats.
Santhosh S; Anandan R; Sini TK; Mathew PT
J Gastroenterol Hepatol; 2007 Jun; 22(6):949-53. PubMed ID: 17504261
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose-dependent manner.
Ozyurt H; Yildirim Z; Kotuk M; Yilmaz HR; Yağmurca M; Iraz M; Söğüt S; Gergerlioglu S
J Appl Toxicol; 2004; 24(4):269-75. PubMed ID: 15300714
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
7. A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine).
Titti G; Lizzio A; Termini C; Negri P; Fazzio S; Mancini C
Int J Clin Pharmacol Ther; 2000 Aug; 38(8):402-7. PubMed ID: 10984014
[TBL] [Abstract][Full Text] [Related]
8. Gastroprotective effect of Terminalia arjuna bark on diclofenac sodium induced gastric ulcer.
Devi RS; Narayan S; Vani G; Shyamala Devi CS
Chem Biol Interact; 2007 Apr; 167(1):71-83. PubMed ID: 17327128
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of erdosteine on short-term global brain ischemia/reperfusion injury in rats.
Ozerol E; Bilgic S; Iraz M; Cigli A; Ilhan A; Akyol O
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):20-4. PubMed ID: 18930779
[TBL] [Abstract][Full Text] [Related]
10. The effects of erdosteine, N-acetylcysteine and vitamin E on nicotine-induced apoptosis of cardiac cells.
Demiralay R; Gürsan N; Erdem H
J Appl Toxicol; 2007; 27(3):247-54. PubMed ID: 17216608
[TBL] [Abstract][Full Text] [Related]
11. Lack of gastric effects of S-(carboxy-methyl)-L-cysteine.
Domschke W; Domschke S; Demling L
Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):213-5. PubMed ID: 941624
[TBL] [Abstract][Full Text] [Related]
12. Erdosteine protection from cigarette smoke-induced loss of alpha 1-antitrypsin activity in rat lungs.
Biagi GL; Fregnan GB; Gazzani G; Vandoni G
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):235-7. PubMed ID: 2786855
[TBL] [Abstract][Full Text] [Related]
13. [ Erdosteine (Mucodox), oral administration].
J Pharm Belg; 2011 Jun; (2):55-6. PubMed ID: 21823444
[No Abstract] [Full Text] [Related]
14. Synthesis and free radical scavenging properties of the enantiomers of erdosteine.
Inglesi M; Nicola M; Fregnan GB; Bradamante S; Pagani G
Farmaco; 1994 Nov; 40(11):703-8. PubMed ID: 7832972
[TBL] [Abstract][Full Text] [Related]
15. Prevention of HCl-ethanol induced gastric mucosal injury in rats by Garcinia cambogia extract and its possible mechanism of action.
Mahendran P; Sabitha KE; Devi CS
Indian J Exp Biol; 2002 Jan; 40(1):58-62. PubMed ID: 12561970
[TBL] [Abstract][Full Text] [Related]
16. Use of mucolytics in COPD: A Delphi consensus study.
Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats.
Fadillioğlu E; Erdoğan H; Söğüt S; Kuku I
J Appl Toxicol; 2003; 23(1):71-4. PubMed ID: 12518339
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological evidence of morphine-induced inhibition of gastric mucus synthesis in rats.
Del Tacca M; Bernardini C; Corsano E; Bertelli A; Rozè C
Int J Tissue React; 1987; 9(5):413-8. PubMed ID: 3117716
[TBL] [Abstract][Full Text] [Related]
19. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
20. Anti-ulcerogenic properties of the aqueous and methanol extracts from the leaves of Solanum torvum Swartz (Solanaceae) in rats.
Nguelefack TB; Feumebo CB; Ateufack G; Watcho P; Tatsimo S; Atsamo AD; Tane P; Kamanyi A
J Ethnopharmacol; 2008 Sep; 119(1):135-40. PubMed ID: 18602980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
